{"schema_version":"1","generated_at":"2026-11-15T07:56:37.637Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kenneth-pennington","json_url":"https://www.findmykol.com/kol/kenneth-pennington/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kenneth-pennington","name":"Kenneth Pennington","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Goshen","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1144200684","openalex":"A5053037859"},"summary":"Kenneth Pennington is an Oncology physician. OpenAlex indexes 32 publications with 757 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":32,"cited_by_count":757,"h_index":10,"latest_activity_year":2022,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00436267","title":"Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery","phase":"PHASE2","status":"UNKNOWN","role":"Overall official","sponsor":"Goshen Health System","source_url":"https://clinicaltrials.gov/study/NCT00436267","trial_url":"https://www.findmykol.com/trial/NCT00436267"},{"nct":"NCT00408551","title":"Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver","phase":"PHASE2","status":"UNKNOWN","role":"Overall official","sponsor":"Goshen Health System","source_url":"https://clinicaltrials.gov/study/NCT00408551","trial_url":"https://www.findmykol.com/trial/NCT00408551"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2022,"amount_usd":113.34,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1144200684"},{"payer":"Gilead Sciences, Inc.","program_year":2021,"amount_usd":11.92,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1144200684"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1144200684","source":"payments"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"OpenAlex author record","recent":[{"title":"Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial","year":2020,"journal":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","source_url":"https://doi.org/10.17615/28jb-2m68","status":"verified"},{"title":"ral World Journal of Surgical Oncology ssBioMed Cent","year":2016,"status":"verified"},{"title":"Phase I study of TH-302, investigational hypoxia-targeted drug, in combination with sunitinib.","year":2013,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e15557","status":"verified"},{"title":"Abstract B77: Phase I study of TH-302, an investigational hypoxia-targeted drug, in combination with sunitinib.","year":2013,"journal":"Molecular Cancer Therapeutics","source_url":"https://doi.org/10.1158/1535-7163.targ-13-b77","status":"verified"},{"title":"Fractionated radioimmunotherapy with 90 Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer","year":2012,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.27592","status":"verified"}],"source":"works"},"contact":{"address_1":"200 HIGH PARK AVE","city":"Goshen","state":"IN","zip":"465264810","phone":"574-535-2888","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1144200684","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":27}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-03-11","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}